Back to Search
DEKE EBERHARD, M.D.
M.D.
Family Medicine Physician
NPI: 1982135299IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
S8704(TX)
Education
OTHER
Class of 2015
Research & Publications (20)
A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses.
PMID 19460940·J Mol Diagn·2009
8-other
The western corn rootworm (Diabrotica virgifera virgifera) and its first appearance in Germany 2007.
PMID 19226788·Commun Agric Appl Biol Sci·2008
7-preclinical
Origin of pancreatic endocrine cells from biliary duct epithelium.
PMID 18810318·Cell Mol Life Sci·2008
7-preclinical
Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
PMID 18281673·J Clin Oncol·2008
6-review
Transdifferentiation and metaplasia as a paradigm for understanding development and disease.
PMID 18030422·Cell Mol Life Sci·2008
6-review
Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer.
PMID 18511480·Mol Cell Proteomics·2008
8-other
Gbx2 and Otx2 interact with the WD40 domain of Groucho/Tle corepressors.
PMID 17060451·Mol Cell Biol·2007
7-preclinical
Green fluorescent protein as a tracer in chimeric tissues: the power of vapor fixation.
PMID 18287644·Methods Mol Biol·2007
7-preclinical
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
PMID 17947484·Clin Cancer Res·2007
3-trial
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
PMID 17721511·Nat Biotechnol·2007
8-other
Highly efficient somatic-mutation identification using Escherichia coli mismatch-repair detection.
PMID 17704782·Nat Methods·2007
8-other
Proton conductivity study of a fuel cell membrane with nanoscale resolution.
PMID 17274094·Chemphyschem·2007
8-other
Beta cells occur naturally in extrahepatic bile ducts of mice.
PMID 17179205·J Cell Sci·2007
4-observational
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.
PMID 16896006·J Clin Oncol·2006
3-trial
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
PMID 15956649·J Natl Cancer Inst·2005
3-trial
Patterns of myocardial histogenesis as revealed by mouse chimeras.
PMID 15680354·Dev Biol·2005
7-preclinical
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
PMID 15753462·J Clin Oncol·2005
3-trial
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
PMID 16043828·J Clin Oncol·2005
3-trial
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.
PMID 16361555·Clin Cancer Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1013 S WELLS ST
EDNA, TX 77957 - Phone
- (361) 782-7820
Quick Facts
- NPI
- 1982135299
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile